TreeWAS – Variant ID: rs35787687

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.066	0.934	0.000
Y45.1 Salicylates	0.062	0.938	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.061	0.939	0.000
Y45.2 Propionic acid derivatives	0.051	0.948	0.000
Y45.5 4-Aminophenol derivatives	0.046	0.954	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.045	0.954	0.000
Y45.4 Antirheumatics	0.044	0.956	0.000
Y45.8 Other analgesics and antipyretics	0.041	0.959	0.000
J69.0 Pneumonitis due to food and vomit	0.000	0.964	0.036
J69 Pneumonitis due to solids and liquids	0.000	0.968	0.032
J60-J70 Lung diseases due to external agents	0.000	0.970	0.030
J67 Hypersensitivity pneumonitis due to organic dust	0.000	0.971	0.029
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.028	0.972	0.000
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.000	0.972	0.028
Y51 Drugs primarily affecting the autonomic nervous system	0.026	0.974	0.000
J64 Unspecified pneumoconiosis	0.000	0.975	0.025
J60 Coalworker's pneumoconiosis	0.000	0.975	0.025
J67.2 Bird fancier's lung	0.000	0.976	0.024
J70 Respiratory conditions due to other external agents	0.000	0.976	0.024
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.024	0.976	0.000
J69.1 Pneumonitis due to oils and essences	0.000	0.977	0.023
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.000	0.977	0.023
J69.8 Pneumonitis due to other solids and liquids	0.000	0.977	0.023
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.000	0.978	0.022
J66 Airway disease due to specific organic dust	0.000	0.978	0.022
J63 Pneumoconiosis due to other inorganic dusts	0.000	0.978	0.022
J62 Pneumoconiosis due to dust containing silica	0.000	0.978	0.022
J65 Pneumoconiosis associated with tuberculosis	0.000	0.978	0.022
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.022	0.978	0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.000	0.979	0.021
J67.7 Air-conditioner and humidifier lung	0.000	0.979	0.021
J67.6 Maple-bark-stripper's lung	0.000	0.979	0.021
J67.5 Mushroom-worker's lung	0.000	0.979	0.021
J67.4 Maltworker's lung	0.000	0.979	0.021
J67.3 Suberosis	0.000	0.979	0.021
J67.1 Bagassosis	0.000	0.979	0.021
J67.0 Farmer's lung	0.000	0.979	0.021
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.020	0.980	0.000
Y45.0 Opioids and related analgesics	0.019	0.980	0.000
Y58 Bacterial vaccines	0.019	0.981	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.000	0.981	0.019
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.019	0.981	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.019	0.981	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.019	0.981	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.019	0.981	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.019	0.981	0.000
Y51.0 Anticholinesterase agents	0.019	0.981	0.000
Y40 Systemic antibiotics	0.019	0.981	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.019	0.981	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.019	0.981	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.018	0.982	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.018	0.982	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.018	0.982	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.000	0.982	0.018
J70.9 Respiratory conditions due to unspecified external agent	0.000	0.983	0.017
J70.8 Respiratory conditions due to other specified external agents	0.000	0.983	0.017
J70.4 Drug-induced interstitial lung disorder, unspecified	0.000	0.983	0.017
J70.3 Chronic drug-induced interstitial lung disorders	0.000	0.983	0.017
J70.2 Acute drug-induced interstitial lung disorders	0.000	0.983	0.017
J70.0 Acute pulmonary manifestations due to radiation	0.000	0.983	0.017
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.017	0.983	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.017	0.983	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.017	0.983	0.000
M47.89 Other spondylosis (Site unspecified)	0.000	0.983	0.017
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.017	0.983	0.000
Y59 Other and unspecified vaccines and biological substances	0.017	0.983	0.000
Y40.9 Systemic antibiotic, unspecified	0.016	0.984	0.000
Y57 Other and unspecified drugs and medicaments	0.016	0.984	0.000
Y58.0 BCG vaccine	0.016	0.984	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.000	0.984	0.016
J62.0 Pneumoconiosis due to talc dust	0.000	0.984	0.016
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.000	0.984	0.016
J63.5 Stannosis	0.000	0.984	0.016
J63.4 Siderosis	0.000	0.984	0.016
J63.3 Graphite fibrosis (of lung)	0.000	0.984	0.016
J63.2 Berylliosis	0.000	0.984	0.016
J63.1 Bauxite fibrosis (of lung)	0.000	0.984	0.016
J63.0 Aluminosis (of lung)	0.000	0.984	0.016
J66.8 Airway disease due to other specific organic dusts	0.000	0.984	0.016
J66.2 Cannabinosis	0.000	0.984	0.016
J66.1 Flax-dresser's disease	0.000	0.984	0.016
J66.0 Byssinosis	0.000	0.984	0.016
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.000	0.984	0.016
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.000	0.984	0.016
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.015	0.985	0.000
Y46.7 Anti-Parkinsonism drugs	0.015	0.985	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.015	0.985	0.000
Y40.6 Rifamycins	0.015	0.985	0.000
Y47.1 Benzodiazepines	0.014	0.985	0.000
Y54.4 Loop [high-ceiling] diuretics	0.014	0.986	0.000
Y48 Anaesthetics and therapeutic gases	0.014	0.986	0.000
Y54.3 Benzothiadiazine derivatives	0.014	0.986	0.000
Y58.9 Other and unspecified bacterial vaccines	0.014	0.986	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.014	0.986	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.014	0.986	0.000
Y58.5 Diphtheria vaccine	0.014	0.986	0.000
Y58.4 Tetanus vaccine	0.014	0.986	0.000
Y58.3 Plague vaccine	0.014	0.986	0.000
Y58.2 Cholera vaccine	0.014	0.986	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.014	0.986	0.000
Y46.2 Hydantoin derivatives	0.014	0.986	0.000
Y40.7 Antifungal antibiotics, systemically used	0.014	0.986	0.000
Y54.5 Other diuretics	0.014	0.986	0.000
Y57.5 X-ray contrast media	0.014	0.986	0.000
Y40.4 Tetracyclines	0.014	0.986	0.000
Y40.2 Chloramphenicol group	0.014	0.986	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.014	0.986	0.000
Y41.4 Anthelminthics	0.014	0.986	0.000
Y41.3 Other antiprotozoal drugs	0.014	0.986	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.014	0.986	0.000
Y41.1 Antimycobacterial drugs	0.014	0.986	0.000
Y46.8 Antispasticity drugs	0.014	0.986	0.000
Y46.5 Valproic acid	0.014	0.986	0.000
Y46.3 Deoxybarbiturates	0.014	0.986	0.000
Y46.1 Oxazolidinediones	0.014	0.986	0.000
Y46.0 Succinimides	0.014	0.986	0.000
Y46.4 Iminostilbenes	0.014	0.986	0.000
Y46.6 Other and unspecified antiepileptics	0.014	0.986	0.000
M47.8 Other spondylosis	0.000	0.986	0.014
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.013	0.986	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.013	0.986	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.013	0.986	0.000
Y47.4 Bromine compounds	0.013	0.986	0.000
Y47.3 Paraldehyde	0.013	0.986	0.000
Y47.2 Chloral derivatives	0.013	0.986	0.000
Y47.0 Barbiturates, not elsewhere classified	0.013	0.986	0.000
Y59.0 Viral vaccines	0.013	0.987	0.000
Y54.9 Mineral salts, not elsewhere classified	0.013	0.987	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.013	0.987	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.013	0.987	0.000
Y54.0 Mineralocorticoids	0.013	0.987	0.000
Y41.0 Sulphonamides	0.013	0.987	0.000
Y54.7 Agents affecting calcification	0.013	0.987	0.000
Y50.9 Central nervous system stimulant, unspecified	0.012	0.987	0.000
Y50.8 Other central nervous system stimulants	0.012	0.987	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.012	0.987	0.000
Y50.1 Opioid receptor antagonists	0.012	0.987	0.000
Y50.0 Analeptics	0.012	0.987	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.987	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.012	0.987	0.000
Y55.5 Anticommon cold drugs	0.012	0.987	0.000
Y55.4 Expectorants	0.012	0.987	0.000
Y55.3 Antitussives	0.012	0.987	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.012	0.987	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.987	0.000
Y55.0 Oxytocic drugs	0.012	0.987	0.000
Y59.9 Vaccine or biological substance, unspecified	0.012	0.987	0.000
Y59.8 Other specified vaccines and biological substances	0.012	0.987	0.000
Y59.2 Protozoal vaccines	0.012	0.987	0.000
Y59.1 Rickettsial vaccines	0.012	0.987	0.000
Y40.0 Penicillins	0.012	0.988	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.000	0.988	0.012
Y57.7 Vitamins, not elsewhere classified	0.012	0.988	0.000
Y57.4 Pharmaceutical excipients	0.012	0.988	0.000
Y57.3 Alcohol deterrents	0.012	0.988	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.012	0.988	0.000
Y57.1 Lipotropic drugs	0.012	0.988	0.000
Y57.0 Appetite depressants [anorectics]	0.012	0.988	0.000
Y57.6 Other diagnostic agents	0.012	0.988	0.000
Y40.5 Aminoglycosides	0.012	0.988	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.012	0.988	0.000
Y44 Agents primarily affecting blood constituents	0.011	0.988	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.011	0.989	0.000
Y56.3 Emollients, demulcents and protectants	0.011	0.989	0.000
Y56.9 Topical agent, unspecified	0.011	0.989	0.000
Y56.8 Other topical agents	0.011	0.989	0.000
Y56.7 Dental drugs, topically applied	0.011	0.989	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.011	0.989	0.000
Y56.5 Ophthalmological drugs and preparations	0.011	0.989	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.011	0.989	0.000
Y56.2 Local astringents and local detergents	0.011	0.989	0.000
Y56.1 Antipruritics	0.011	0.989	0.000
M47.84 Other spondylosis (Thoracic region)	0.000	0.989	0.011
Y54.8 Agents affecting uric acid metabolism	0.011	0.989	0.000
Y59.3 Immunoglobulin	0.011	0.989	0.000
M47.86 Other spondylosis (Lumbar region)	0.000	0.989	0.011
Y52 Agents primarily affecting the cardiovascular system	0.011	0.989	0.000
Y40.3 Macrolides	0.011	0.989	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.011	0.989	0.000
Y53.7 Emetics	0.011	0.989	0.000
Y53.6 Antidiarrhoeal drugs	0.011	0.989	0.000
Y53.5 Digestants	0.011	0.989	0.000
Y53.3 Saline and osmotic laxatives	0.011	0.989	0.000
Y53.2 Stimulant laxatives	0.011	0.989	0.000
Y53.0 Histamine H2-receptor antagonists	0.011	0.989	0.000
Y41.5 Antiviral drugs	0.011	0.989	0.000
Y53.4 Other laxatives	0.010	0.989	0.000
Y48.5 Therapeutic gases	0.010	0.989	0.000
Y48.1 Parenteral anaesthetics	0.010	0.989	0.000
Y48.0 Inhaled anaesthetics	0.010	0.989	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
Y48.2 Other and unspecified general anaesthetics	0.010	0.990	0.000
Y57.8 Other drugs and medicaments	0.010	0.990	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.000	0.990	0.010
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.000	0.990	0.010
Y53.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990	0.000
Y57.9 Drug or medicament, unspecified	0.009	0.991	0.000
Y48.4 Anaesthetic, unspecified	0.009	0.991	0.000
H90 Conductive and sensorineural hearing loss	0.009	0.991	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.009	0.991	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.000	0.991	0.009
I61 Intracerebral haemorrhage	0.000	0.991	0.009
Y48.3 Local anaesthetics	0.009	0.991	0.000
H90.2 Conductive hearing loss, unspecified	0.009	0.991	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.991	0.009
Y43 Primarily systemic agents	0.009	0.991	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
Y52.1 Calcium-channel blockers	0.009	0.991	0.000
Y49.9 Psychotropic drug, unspecified	0.008	0.991	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.008	0.991	0.000
Y49.7 Psychostimulants with abuse potential	0.008	0.991	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.008	0.991	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.991	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.991	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.008	0.991	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.008	0.991	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.991	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.008	0.991	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.008	0.991	0.000
Y44.7 Plasma substitutes	0.008	0.991	0.000
Y44.6 Natural blood and blood products	0.008	0.991	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.008	0.991	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.008	0.991	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.008	0.992	0.000
H90.0 Conductive hearing loss, bilateral	0.008	0.992	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.000	0.992	0.008
Y52.8 Antivaricose drugs, including sclerosing agents	0.008	0.992	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.008	0.992	0.000
Y52.7 Peripheral vasodilators	0.008	0.992	0.000
H90.3 Sensorineural hearing loss, bilateral	0.008	0.992	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.008	0.992	0.000
H90.5 Sensorineural hearing loss, unspecified	0.008	0.992	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.000	0.992	0.008
S70.9 Superficial injury of hip and thigh, unspecified	0.008	0.992	0.000
Y44.5 Thrombolytic drugs	0.007	0.992	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.007	0.993	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.000	0.993	0.007
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.007	0.993	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.007	0.993	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.000	0.993	0.007
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.007	0.993	0.000
Y49.2 Other and unspecified antidepressants	0.007	0.993	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.000	0.993	0.007
Y40.8 Other systemic antibiotics	0.007	0.993	0.000
I61.8 Other intracerebral haemorrhage	0.000	0.993	0.007
Y43.4 Immunosuppressive agents	0.007	0.993	0.000
Y42.1 Thyroid hormones and substitutes	0.007	0.993	0.000
Y42.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.000	0.993	0.007
N70 Salpingitis and oophoritis	0.000	0.993	0.007
Y43.9 Primarily systemic agent, unspecified	0.007	0.993	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.007	0.993	0.000
Y43.6 Enzymes, not elsewhere classified	0.007	0.993	0.000
Y43.5 Acidifying and alkalising agents	0.007	0.993	0.000
Y43.2 Antineoplastic natural products	0.007	0.993	0.000
Y42.4 Oral contraceptives	0.006	0.993	0.000
Y42.2 Antithyroid drugs	0.006	0.993	0.000
Y44.2 Anticoagulants	0.006	0.993	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.000	0.994	0.006
B37.8 Candidiasis of other sites	0.000	0.994	0.006
I61.5 Intracerebral haemorrhage, intraventricular	0.000	0.994	0.006
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.006	0.994	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.994	0.006
I61.4 Intracerebral haemorrhage in cerebellum	0.000	0.994	0.006
Y49.5 Other antipsychotics and neuroleptics	0.006	0.994	0.001
Y52.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
Y42.5 Other oestrogens and progestogens	0.006	0.994	0.000
Y43.1 Antineoplastic antimetabolites	0.006	0.994	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.994	0.006
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.006	0.994	0.000
Y43.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
N70.0 Acute salpingitis and oophoritis	0.000	0.994	0.006
O47.1 False labour at or after 37 completed weeks of gestation	0.006	0.994	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.005	0.994	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.005	0.995	0.000
I26.9 Pulmonary embolism without mention of acute cor pulmonale	0.000	0.995	0.005
Y42.0 Glucocorticoids and synthetic analogs	0.005	0.995	0.000
Y42.7 Androgens and anabolic congeners	0.005	0.995	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.995	0.005
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.995	0.005
H65.3 Chronic mucoid otitis media	0.005	0.995	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.995	0.005
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.995	0.005
H44.2 Degenerative myopia	0.005	0.995	0.000
T14.0 Superficial injury of unspecified body region	0.005	0.995	0.000
N30.2 Other chronic cystitis	0.000	0.995	0.005
M47 Spondylosis	0.000	0.995	0.005
H65 Nonsuppurative otitis media	0.005	0.995	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.995	0.005
K61.0 Anal abscess	0.004	0.996	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
N73.9 Female pelvic inflammatory disease, unspecified	0.000	0.996	0.004
S32.7 Multiple fractures of lumbar spine and pelvis	0.004	0.996	0.000
H65.1 Other acute nonsuppurative otitis media	0.004	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.996	0.001
M47.2 Other spondylosis with radiculopathy	0.000	0.996	0.004
O75.2 Pyrexia during labour, not elsewhere classified	0.004	0.996	0.000
M79.00 Rheumatism, unspecified (Multiple sites)	0.000	0.996	0.004
X23.9 Unspecified place	0.004	0.996	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.996	0.004
D22.5 Melanocytic naevi of trunk	0.000	0.996	0.004
M47.0 Anterior spinal and vertebral artery compression syndromes	0.000	0.996	0.003
K51.0 Ulcerative (chronic) enterocolitis	0.004	0.996	0.000
R49.0 Dysphonia	0.000	0.996	0.004
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.000	0.996	0.004
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.003	0.997	0.000
H65.0 Acute serous otitis media	0.003	0.997	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.997	0.003
M79.0 Rheumatism, unspecified	0.000	0.997	0.003
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.997	0.003
N30 Cystitis	0.000	0.997	0.003
H65.4 Other chronic nonsuppurative otitis media	0.003	0.997	0.000
N30.3 Trigonitis	0.000	0.997	0.003
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.000	0.997	0.003
S70 Superficial injury of hip and thigh	0.003	0.997	0.000
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.003	0.997	0.000
X23 Contact with hornets, wasps and bees	0.003	0.997	0.000
K51.5 Mucosal proctocolitis	0.003	0.997	0.000
M47.1 Other spondylosis with myelopathy	0.000	0.997	0.003
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.000	0.997	0.003
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.000	0.997	0.003
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.000	0.997	0.003
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.000	0.997	0.003
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.000	0.997	0.003
K81.9 Cholecystitis, unspecified	0.003	0.997	0.000
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.997	0.003
K51.2 Ulcerative (chronic) proctitis	0.003	0.997	0.000
F32.0 Mild depressive episode	0.000	0.997	0.003
H65.2 Chronic serous otitis media	0.003	0.997	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.997	0.003
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.000	0.997	0.003
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.000	0.997	0.003
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.000	0.997	0.003
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.000	0.997	0.003
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.000	0.997	0.003
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.000	0.997	0.003
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.000	0.997	0.003
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.000	0.997	0.003
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.000	0.997	0.003
S70.8 Other superficial injuries of hip and thigh	0.003	0.997	0.000
S70.7 Multiple superficial injuries of hip and thigh	0.003	0.997	0.000
K51 Ulcerative colitis	0.003	0.997	0.000
M67.43 Ganglion, wrist	0.003	0.997	0.000
W57.0 Home	0.003	0.997	0.000
X23.0 Home	0.003	0.997	0.000
T14 Injury of unspecified body region	0.003	0.997	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.003	0.997	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.997	0.003
N76.0 Acute vaginitis	0.000	0.997	0.003
Z98.8 Other specified postsurgical states	0.000	0.997	0.003
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.000	0.997	0.002
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.997	0.003
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.997	0.003
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M79.04 Rheumatism, unspecified (Hand)	0.000	0.997	0.003
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.997	0.003
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.997	0.003
N30.4 Irradiation cystitis	0.000	0.997	0.003
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.997	0.003
Y65.4 Failure to introduce or to remove other tube or instrument	0.003	0.997	0.000
X20-X29 Contact with venomous animals and plants	0.003	0.997	0.000
W57.8 Other specified place	0.003	0.997	0.000
M67.47 Ganglion, ankle and foot	0.003	0.997	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.997	0.002
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.003	0.997	0.000
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.997	0.003
K41 Femoral hernia	0.000	0.997	0.003
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.997	0.003
T14.6 Injury of tendons and muscles of unspecified body region	0.003	0.997	0.000
X23.8 Other specified place	0.002	0.997	0.000
X23.7 Farm	0.002	0.997	0.000
X23.6 Industrial and construction area	0.002	0.997	0.000
X23.5 Trade and service area	0.002	0.997	0.000
X23.4 Street and highway	0.002	0.997	0.000
X23.3 Sports and athletics area	0.002	0.997	0.000
X23.2 School, other institution and public administrative area	0.002	0.997	0.000
X23.1 Residential institution	0.002	0.997	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.003	0.997	0.000
Y65 Other misadventures during surgical and medical care	0.003	0.997	0.000
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.000	0.997	0.002
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.000	0.997	0.002
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.000	0.997	0.002
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.000	0.997	0.002
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.000	0.997	0.002
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.000	0.997	0.002
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.000	0.997	0.002
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.000	0.997	0.002
K51.4 Pseudopolyposis of colon	0.002	0.997	0.000
N30.0 Acute cystitis	0.000	0.997	0.002
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
M79.08 Rheumatism, unspecified (Other)	0.000	0.998	0.002
J39.2 Other diseases of pharynx	0.000	0.998	0.002
F32 Depressive episode	0.000	0.998	0.002
H44 Disorders of globe	0.002	0.998	0.000
I26 Pulmonary embolism	0.000	0.998	0.002
V01 Pedestrian injured in collision with pedal cycle	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.002	0.998	0.000
F25.9 Schizoaffective disorder, unspecified	0.000	0.998	0.002
H70.9 Mastoiditis, unspecified	0.002	0.998	0.000
T78.2 Anaphylactic shock, unspecified	0.002	0.998	0.000
Y65.8 Other specified misadventures during surgical and medical care	0.002	0.998	0.000
S70.1 Contusion of thigh	0.002	0.998	0.000
V01.9 Unspecified whether traffic or nontraffic accident	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
F32.8 Other depressive episodes	0.000	0.998	0.002
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.998	0.002
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.000	0.998	0.002
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.998	0.002
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
V01-V09 Pedestrian injured in transport accident	0.002	0.998	0.000
M67.4 Ganglion	0.002	0.998	0.000
V40-V49 Car occupant injured in transport accident	0.002	0.998	0.000
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.998	0.002
T14.2 Fracture of unspecified body region	0.002	0.998	0.000
T14.8 Other injuries of unspecified body region	0.002	0.998	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.002	0.998	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.002	0.998	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.002	0.998	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.002	0.998	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
K43 Ventral hernia	0.000	0.998	0.002
M47.12 Other spondylosis with myelopathy (Cervical region)	0.000	0.998	0.002
V28.9 Unspecified motorcycle rider injured in traffic accident	0.002	0.998	0.000
W57.9 Unspecified place	0.002	0.998	0.000
W57.7 Farm	0.002	0.998	0.000
W57.6 Industrial and construction area	0.002	0.998	0.000
W57.5 Trade and service area	0.002	0.998	0.000
W57.4 Street and highway	0.002	0.998	0.000
W57.3 Sports and athletics area	0.002	0.998	0.000
W57.2 School, other institution and public administrative area	0.002	0.998	0.000
W57.1 Residential institution	0.002	0.998	0.000
H44.0 Purulent endophthalmitis	0.002	0.998	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.002	0.998	0.000
Z90.2 Acquired absence of lung [part of]	0.000	0.998	0.002
V01.1 Traffic accident	0.002	0.998	0.000
A46 Erysipelas	0.000	0.998	0.002
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
K51.8 Other ulcerative colitis	0.002	0.998	0.000
X29 Contact with unspecified venomous animal or plant	0.002	0.998	0.000
X28 Contact with other specified venomous plants	0.002	0.998	0.000
X27 Contact with other specified venomous animals	0.002	0.998	0.000
X26 Contact with venomous marine animals and plants	0.002	0.998	0.000
X25 Contact with other specified venomous arthropods	0.002	0.998	0.000
X24 Contact with centipedes and venomous millipedes (tropical)	0.002	0.998	0.000
X22 Contact with scorpions	0.002	0.998	0.000
X21 Contact with venomous spiders	0.002	0.998	0.000
X20 Contact with venomous snakes and lizards	0.002	0.998	0.000
M47.9 Spondylosis, unspecified	0.000	0.998	0.002
V02 Pedestrian injured in collision with two- or three-wheeled motor vehicle	0.002	0.998	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.998	0.002
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.000	0.998	0.002
K41.1 Bilateral femoral hernia, with gangrene	0.000	0.998	0.002
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.000	0.998	0.002
V19 Pedal cyclist injured in other and unspecified transport accidents	0.002	0.998	0.000
T14.1 Open wound of unspecified body region	0.002	0.998	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.002	0.998	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.002	0.998	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.002	0.998	0.000
Y65.5 Performance of inappropriate operation	0.002	0.998	0.000
Y65.3 Endotracheal tube wrongly placed during anaesthetic procedure	0.002	0.998	0.000
Y65.2 Failure in suture or ligature during surgical operation	0.002	0.998	0.000
Y65.1 Wrong fluid used in infusion	0.002	0.998	0.000
Y65.0 Mismatched blood used in transfusion	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.000	0.998	0.002
H16.0 Corneal ulcer	0.002	0.998	0.000
K51.1 Ulcerative (chronic) ileocolitis	0.002	0.998	0.000
Y61 Foreign object accidentally left in body during surgical and medical care	0.002	0.998	0.000
V02.1 Traffic accident	0.002	0.998	0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.002	0.998	0.000
H70 Mastoiditis and related conditions	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.000	0.998	0.002
W60 Contact with plant thorns and spines and sharp leaves	0.002	0.998	0.000
H44.8 Other disorders of globe	0.002	0.998	0.000
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.000	0.998	0.002
Z87.0 Personal history of diseases of the respiratory system	0.000	0.998	0.002
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.002	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.002	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
H44.3 Other degenerative disorders of globe	0.002	0.998	0.000
T63.4 Venom of other arthropods	0.002	0.998	0.000
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.002	0.998	0.000
H50.9 Strabismus, unspecified	0.002	0.998	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.002	0.998	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.998	0.002
V01.0 Nontraffic accident	0.002	0.998	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations